Shanghai Kaibao Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Kaibao Pharmaceutical Company Limited with three other
companies in this sector in China:
Guilin Sanjin Pharmaceutical Co Ltd
sales of 1.53 billion Chinese Renmimbi [US$225.93 million]
of which 94%
was Proprietary Chinese medicine),
Shandong Shanda Wit Science and Technology Co Ltd
(1.54 billion Chinese Renmimbi [US$228.68 million]
of which 57%
was Medicines), and
Jinhe Biotechnology Co Ltd
(1.50 billion Chinese Renmimbi [US$221.50 million]
of which 72%
was Medical Feeds Additives).
During the year ended December of 2016, sales at
Shanghai Kaibao Pharmaceutical Company Limited were 1.50 billion Chinese Renmimbi (US$221.77 million).
increase of 7.3%
versus 2015, when the company's sales were 1.40 billion Chinese Renmimbi.